WO2017210619A1 - Cooling systems and methods for skin treatment - Google Patents
Cooling systems and methods for skin treatment Download PDFInfo
- Publication number
- WO2017210619A1 WO2017210619A1 PCT/US2017/035791 US2017035791W WO2017210619A1 WO 2017210619 A1 WO2017210619 A1 WO 2017210619A1 US 2017035791 W US2017035791 W US 2017035791W WO 2017210619 A1 WO2017210619 A1 WO 2017210619A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- cooling
- treatment
- duration
- time
- Prior art date
Links
- 238000001816 cooling Methods 0.000 title claims abstract description 359
- 238000011282 treatment Methods 0.000 title claims abstract description 271
- 238000000034 method Methods 0.000 title claims abstract description 82
- 230000008014 freezing Effects 0.000 claims abstract description 62
- 238000007710 freezing Methods 0.000 claims abstract description 62
- 238000004781 supercooling Methods 0.000 claims abstract description 17
- 238000002203 pretreatment Methods 0.000 claims description 53
- 208000012641 Pigmentation disease Diseases 0.000 claims description 15
- 239000013078 crystal Substances 0.000 claims description 13
- 230000015572 biosynthetic process Effects 0.000 claims description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 10
- 230000000977 initiatory effect Effects 0.000 claims description 9
- 230000019612 pigmentation Effects 0.000 claims description 9
- 230000003287 optical effect Effects 0.000 claims description 4
- 238000009530 blood pressure measurement Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 208000000069 hyperpigmentation Diseases 0.000 abstract description 8
- 230000003810 hyperpigmentation Effects 0.000 abstract description 8
- 230000002411 adverse Effects 0.000 abstract description 6
- 230000001976 improved effect Effects 0.000 abstract description 6
- 208000031040 hypopigmentation of the skin Diseases 0.000 abstract description 2
- 239000000523 sample Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 248
- 210000001519 tissue Anatomy 0.000 description 58
- 239000000463 material Substances 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 208000003367 Hypopigmentation Diseases 0.000 description 12
- 230000003425 hypopigmentation Effects 0.000 description 12
- 238000012546 transfer Methods 0.000 description 9
- 210000002615 epidermis Anatomy 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 238000002604 ultrasonography Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 230000001960 triggered effect Effects 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 210000002780 melanosome Anatomy 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010033546 Pallor Diseases 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- -1 fine particulates Inorganic materials 0.000 description 2
- 230000006910 ice nucleation Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 2
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 1
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010059284 Epidermal necrosis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002681 cryosurgery Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/0085—Devices for generating hot or cold treatment fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/008—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms using shock waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0052—Body part for treatment of skin or hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
- A61F2007/0063—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
- A61F2007/0075—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating using a Peltier element, e.g. near the spot to be heated or cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0086—Heating or cooling appliances for medical or therapeutic treatment of the human body with a thermostat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0087—Hand-held applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0093—Heating or cooling appliances for medical or therapeutic treatment of the human body programmed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0095—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator
- A61F2007/0096—Heating or cooling appliances for medical or therapeutic treatment of the human body with a temperature indicator with a thermometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0295—Compresses or poultices for effecting heating or cooling for heating or cooling or use at more than one temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0295—Compresses or poultices for effecting heating or cooling for heating or cooling or use at more than one temperature
- A61F2007/0296—Intervals of heating alternated with intervals of cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/01—Constructive details
- A61H2201/0119—Support for the device
- A61H2201/0153—Support for the device hand-held
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0214—Characteristics of apparatus not provided for in the preceding codes heated or cooled cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0221—Mechanism for heating or cooling
- A61H2201/0257—Mechanism for heating or cooling by a heat accumulator, e.g. a sand or liquid reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0221—Mechanism for heating or cooling
- A61H2201/0285—Mechanism for heating or cooling with Peltier elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/50—Control means thereof
- A61H2201/5023—Interfaces to the user
- A61H2201/5025—Activation means
- A61H2201/5028—Contact activation, i.e. activated at contact with a surface of the user to be treated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/50—Control means thereof
- A61H2201/5058—Sensors or detectors
- A61H2201/5061—Force sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2230/00—Measuring physical parameters of the user
- A61H2230/50—Temperature
- A61H2230/505—Temperature used as a control parameter for the apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0218—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with alternating magnetic fields producing a translating or oscillating movement
- A61H23/0236—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with alternating magnetic fields producing a translating or oscillating movement using sonic waves, e.g. using loudspeakers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0245—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with ultrasonic transducers, e.g. piezoelectric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0254—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with rotary motor
- A61H23/0263—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with rotary motor using rotating unbalanced masses
Definitions
- Embodiments of the present invention generally relate to methods, devices, and systems for reducing a pigmentation of a skin of a patient. More specifically, embodiments generally relate to methods, devices, and systems to increase the consistency of skin treatment by reliably freezing (water phase transition) the skin during treatment and limiting adverse side effects from the skin freezing.
- Controlled freezing of biological tissue can produce various effects.
- Certain tissue freezing procedures and devices such as conventional cryoprobes, can cause severe freezing of tissue and generate cellular damage. It has been observed that moderate degrees of freezing can produce particular effects, such as affecting the expression of skin pigmentation (e.g., hypopigmentation).
- hyperpigmented areas are typically associated with excess melanin within the epidermis; however, they can also result from excess melanin deposited within the dermis.
- Hypopigmentation of skin tissue has been observed as a side effect in response to temporary cooling or freezing of the tissue, such as may occur during cryosurgery procedures. Loss of pigmentation following skin cooling or freezing may result from decreased melanin production, decreased melanosome production, destruction of
- melanocytes or inhibited transfer of melanosome into the keratinocytes in the lower region of the epidermal layer.
- the resultant hypopigmentation may be long-lasting or permanent.
- some of these freezing procedures can generate regions of hyperpigmentation (or skin darkening) of skin tissue.
- the level of increase or decrease in pigmentation may be dependent upon certain aspects of the cooling or freezing conditions, including the temperature of the cooling treatment, and the length of time the tissue is maintained in a frozen state.
- the skin may sometimes freeze toward the beginning of the cooling treatment, or may sometimes cool to a temperature below the freezing point (e.g., 0 to -5 °C) for a period and then freeze some variable time thereafter.
- the skin may become supercooled (cooled to a temperature below the freezing point) and may not freeze at all during the cooling treatment.
- Such variability in the skin freezing i.e., the formation of water ice in the skin
- prolonging treatment and/or applying colder temperatures is not necessarily a solution as it may result in adverse side effects such as hyperpigmentation.
- hypopigmentation treatments in particular hypopigmentation treatments provided via skin freezing.
- At least some embodiments of the present invention may provide additional control over the occurrence of freezing and may limit supercooling of the skin during a cooling treatment. Additionally, at least some embodiments may provide skin treatment while limiting adverse side effects, such as hyperpigmentation.
- the present invention generally relates to improved medical devices, systems, and methods, with exemplary embodiments providing improved cooling treatment probes and cooling treatment methods and systems.
- freezing of the skin may be desirable to effect the hypopigmentation of the skin of the patient.
- embodiments may limit supercooling of the skin of the patient during a cooling treatment. Additionally, embodiments may limit adverse side effects such as hyperpigmentation.
- a method of altering pigmentation in a skin of a patient may be provided.
- the method may include pre-cooling a cooling applicator of a treatment device to a pre-treatment temperature prior to contact of the cooling applicator with a skin surface of the patient.
- the pre-treatment temperature may be colder than a treatment temperature.
- the cooling applicator may be driven toward the pre-treatment temperature for a first duration of time to pre-condition the skin to freeze.
- the cooling applicator may be adjusted toward the treatment temperature for a second duration of time.
- the treatment temperature may be configured to freeze at least a portion of the skin tissue in contact with the cooling applicator.
- the second duration of time may be longer than the first duration of time.
- the treatment temperature may be below 0 °C.
- the pre-treatment temperature may be in a range from -10 °C to -20 °C.
- the treatment temperature may be in a range from -2 °C to -10 °C.
- the second duration of time may be three to ten times longer in duration than the first duration of time. In certain embodiments, the second duration of time may be less than 5 seconds.
- the method may further include adjusting the cooling applicator toward a post- treatment temperature that is higher than the treatment temperature after the second duration of time and while the cooling applicator is positioned and maintained against the skin.
- the post-treatment temperature may be applied so as to thaw the frozen skin tissue.
- a thermoelectric cooler is thermally coupled with the cooling applicator. Adjusting the cooling applicator to the post-treatment temperature may include the step of reversing a current through the thermoelectric cooler. Optionally, the current may be reversed until the cooling applicator reaches the post-treatment temperature.
- the post-treatment temperature is above 0 °C.
- the post treatment temperature may be less than 10 °C, or less than less than 40 °C.
- the cooling applicator may be maintained in contact with the skin at the post-treatment temperature until the frozen portion of skin thaws.
- a method of treating a skin of a patient includes cooling a cooling applicator of a treatment device to a pre-treatment temperature prior to contacting the skin with the cooling applicator of the treatment device.
- the pre- treatment temperature may be colder than a treatment temperature.
- the pre-treatment temperature may be configured to pre-condition at least a portion of the skin to freeze.
- the cooling applicator may then be placed onto the skin and the treatment device may cool the cooling applicator toward the pre-treatment temperature during the first duration of time. After the first duration of time, the cooling applicator may be maintained against the skin for a second duration of time while the treatment device adjusts the cooling applicator toward the treatment temperature.
- the cooling applicator may be removed from the skin of the patient after treating the skin to the treatment temperature using the cooling applicator of the treatment device.
- the second duration of time may be longer than the first duration of time.
- a skin treatment system may include a cooling applicator for contacting a skin of a patient, a cooling arrangement thermally coupled with the cooling applicator; and a controller operably coupled with the cooling arrangement.
- the controller may be configured to control the cooling arrangement to provide a cooling treatment cycle.
- the cooling treatment cycle may include pre-cooling of the cooling applicator to a pre- treatment temperature prior to contact with the skin of the patient and cooling of the cooling applicator toward the pre-treatment temperature for a first duration of time after the cooling applicator is placed against the skin of the patient.
- the cooling treatment cycle may further include, after the first duration of time, adjustment of the temperature of the cooling applicator toward a treatment temperature that is higher than the pre-treatment temperature while the cooling applicator is held against the skin and cooling of the cooling applicator toward the treatment temperature for a second duration of time while the cooling applicator is held against the skin.
- the second duration of time may be longer than the first duration of time.
- the treatment temperature may be below zero.
- the pre-treatment temperature may be -10 °C to -20 °C.
- the treatment temperature may be -2 °C to -10 °C.
- the second duration of time may be three to ten times longer in duration than the first duration of time. In some embodiments, the second duration of time may be less than 5 seconds.
- the cooling treatment cycle may further include, after the second duration of time and while the cooling applicator is placed against the skin, adjustment of the temperature of the cooling applicator toward a post-treatment temperature that is higher than the treatment temperature.
- the cooling applicator may be a thermoelectric cooler.
- the controller may adjust the cooling applicator toward the post-treatment temperature by reversing a current through the thermoelectric cooler.
- the post-treatment temperature may be above 0 °C.
- the post-treatment temperature may be less than 10 °C, or less than 40 °C in certain embodiments.
- the device may further comprise a force sensor coupled with the controller.
- the force sensor may be configured to measure a force between the cooling applicator and the skin of a patient.
- the first duration of time or the second duration of time may be variable based on the force measured by the force sensor.
- the device may further include a force sensor coupled with the controller.
- the force sensor may be configured to measure a force between the cooling applicator and the skin of a patient.
- the pre-treatment temperature or the treatment temperature may be variable based on the force measured by the force sensor.
- the device may include a contact sensor coupled with the controller.
- the contact sensor may be configured to determine contact between the cooling applicator and the skin of the patient.
- the controller may initiate the cooling treatment cycle based on skin contact as determined by the contact sensor.
- a contact sensor may be coupled with the controller.
- the contact sensor may be configured to determine contact between the cooling applicator and the skin of the patient.
- the controller may return the cooling arrangement to the pre-treatment temperature when skin contact is not sensed by the contact sensor.
- a method of reducing melanin in a skin of a patient using a cooling applicator of a treatment device may be provided.
- the method may include pre- cooling the cooling applicator to a pre-treatment temperature of -10 °C to -20 °C prior to positioning cooling applicator in contact with the skin; cooling the cooling applicator toward the pre-treatment temperature for a first duration of time after the cooling applicator has been positioned onto the skin; after the first duration of time and while the cooling applicator is placed against the skin, adjusting the cooling applicator toward a treatment temperature of -2 °C to -12 °C for a second duration of time that is longer than the first duration of time; and after the second duration of time and while the cooling applicator is placed against the skin, adjusting the cooling applicator toward a post-treatment temperature between 0 °C to 40 °C.
- the cooling applicator can be adjusted toward a treatment temperature of -2 °C to -10 °C. In some embodiments, the cooling applicator can be adjusted toward a post-treatment temperature between 0 °C to 10 °C or between 0 °C to 40 °C.
- a skin pigmentation treatment system may include a cooling applicator for contacting a skin of a patient; a thermoelectric cooler thermally coupled with the cooling applicator; and a controller operably coupled with the
- thermoelectric cooler The controller may be configured to control a current to the thermoelectric cooler to provide a cooling treatment cycle.
- the cooling treatment cycle may include application of a current to the thermoelectric cooler to cool the cooling applicator toward a treatment temperature while the cooling applicator is held against the skin for a duration of time; and, after the duration of time, reversing the current to the thermoelectric cooler to adjust a temperature of the cooling applicator toward a post-treatment temperature while the cooling applicator is held against the skin.
- the post-treatment temperature may be less than 10 °C or less than 40 °C.
- a method of altering pigmentation in a skin of a patient includes supercooling the skin of the patient by placing a cooling applicator of a treatment device against a skin surface. After supercooling the skin, the method may include applying vibrations to the skin of the patient to facilitate ice crystal formation in the supercooled skin.
- the skin of the patient may be supercooled for a
- the method may include maintaining the cooling applicator against the skin surface for a first duration of time. After the first duration of time, and while the cooling applicator is positioned and maintained against the skin, the method may include adjusting the temperature toward a post-treatment temperature to thaw the frozen skin tissue.
- the post-treatment temperature may be between 0 °C to 10 °C or between 0 °C to 40 °C.
- the first duration of time may be between 10-30 seconds.
- the cooling applicator may be driven toward a treatment temperature during the first duration of time. The treatment temperature may be between -2 °C to -10 °C or between -2 °C to -12 °C.
- the treatment temperature or the first duration of time may be variable based on a force between the cooling applicator and the skin of the patient.
- the method may include returning the cooling applicator of the treatment device toward an idle state based on a signal from a contact sensor indicating removal of the cooling applicator from the skin of the patient.
- a skin treatment system may be provided that includes a cooling applicator for contacting a skin of a patient, a cooling arrangement thermally coupled with the cooling applicator, and a controller operably coupled with the cooling arrangement and a vibrator.
- the controller may be configured to control the cooling arrangement and the vibrator to provide a cooling treatment.
- the cooling treatment may include cooling of the cooling applicator to supercool the skin of the patient and application of the vibrator to deliver vibrations into the supercooled skin to facilitate ice formation in the skin.
- the controller may be configured to supercool the skin of the patient for a predetermined amount of time before applying vibrations from the vibrator.
- the controller may be configured to adjust the cooling applicator to a treatment temperature for a first duration of time after applying vibrations to the skin of the patient.
- the controller may be configured to adjust the temperature of the cooling applicator toward a post-treatment temperature to thaw the frozen skin tissue after the first duration of time, and while the cooling applicator is positioned and maintained against the skin.
- the post-treatment temperature may be between 0 °C to 10 °C, or between 0 °C to 40 °C.
- the first duration of time may be between 10-30 seconds.
- the treatment temperature may be between -2 °C to -10 °C.
- the device may further include a force sensor coupled with the controller.
- the force sensor may be configured to measure a force between the cooling applicator and the skin of the patient.
- the treatment temperature or the first duration of time may be variable based on a force between the cooling applicator and the skin of the patient.
- the system may further include a contact sensor coupled with the controller.
- the controller may be configured to return the cooling applicator of the treatment device toward an idle state based on a signal from a contact sensor indicating removal of the cooling applicator from the skin of the patient.
- Figure 1 illustrates an exemplary treatment method according to some embodiments of the present invention.
- Figures 2-2E illustrate cross-sectional side views of exemplary apparatuses that can be used to produce hypopigmentation in a skin tissue according to some embodiments of the present invention.
- Figure 3 illustrates an exemplary method for delivering treatment cycles according to some embodiments.
- Figure 4 illustrates a cross-sectional view of an exemplary treatment device with one or more force sensors according to some embodiments.
- Figure 5 illustrates another exemplary treatment method according to some embodiments of the present invention.
- Figure 6 illustrates another exemplary cooling apparatus that can be used to produce hypopigmentation in skin tissue according to some embodiments of the present invention.
- some embodiments of the present invention may be directed to techniques to affect melanocytes and/or keratinocytes of a patient.
- some embodiments may be directed to methods and systems for reducing skin pigmentation by cooling the skin of a patient.
- it may be beneficial to freeze the skin.
- it may be advantageous to freeze the skin in a more controllable and consistent manner.
- the freezing event although it may not be required, has been shown to have an effect on both the desired outcome of reduced pigmentation, but also the short term side effects of epidermal necrosis and in some cases prolonged erythema and hyperpigmentation. In previous studies, the timing of skin freezing has been found to be inconsistent.
- some embodiments of the present invention provide increased control over the occurrence of freezing in the skin of a patient and may limit supercooling in the skin.
- Methods and systems described herein may thus increase the chance, predictability, and/or consistency of freezing in the skin of a patient (e.g., repeatable freezing at certain temperatures and/or cooling rates) and may thereby provide additional control over a duration of skin freezing during treatment.
- Some embodiments may be directed to limiting supercooling of the skin of a patient during a cooling treatment. Supercooling of the skin may be cooling of the skin below the water freezing point without solidification or crystallization of water in the skin.
- a number of cooling systems have been developed for lightening the pigmentation of skin (see e.g., U.S. Patent Publication 2011/0313411 filed August 7, 2009; U.S. Patent Publication 2014/0303696 filed November 16, 2012; U.S. Patent Publication 2014/0303697 filed November 16, 2012; U.S. Patent Publication 2015/0223975 filed February 12, 2015 and U.S. Patent Application 15/257,827 filed September 6, 2016, the contents of which are incorporated herein by reference in their entirety).
- the systems provide a cooling contact surface configured to contact and freeze skin tissue (typically the superficial layer of skin down to the dermal/epidermal junction).
- the freezing of the skin tissue may decrease melanin production, decrease melanosome production, destroy melanoncytes, and/or inhibit transfer of melanosomes into keratinocytes in the lower region of the epidermal layer, thereby leading to skin lightening (i.e., hypopigmentation) for a period of time or permanently.
- Some treatments may use relatively modest skin cooling to temperatures in the range of 0 °C to -20 °C over fairly short times frames, e.g., as short as 15 seconds or less and up to 2 minutes or more.
- skin cooling may be performed by controlling the temperature of an aluminum plate (e.g. cooler or cooling applicator) and applying the cooler directly to the skin -- thereby cooling the skin through thermal conduction from the skin to the cooler.
- an aluminum plate e.g. cooler or cooling applicator
- controlling certain aspects of the interface between the cooling applicator and the skin may modify freezing behavior of the skin. For example, freezing may be triggered more reliably by specifying and maintaining a fluid at the interface between the applied applicator and the skin.
- Water is a coupling fluid that can be used to reduce the thermal contact resistance between the applicator and the skin and thereby improve cooling.
- Water can either be pure or contain a thickening agent to increase viscosity.
- Water has a freezing point generally of 0 °C which is very near that of the tissue. However water, particularly in small quantities, has been known to supercool below its typical freezing point, particularly at slower rates of cooling.
- Substances can therefore be mixed with the water to minimize the chance of supercooling but not significantly decrease the freezing point, which would be undesirable.
- Some such substances are inorganic materials such as soot, dust, fine particulates, or silver iodide crystals.
- Other materials that can be added are organic substances such as proteins, lipoproteins, bacteria or fungi. Long chain aliphatic alcohols and amino acids, such as l-aspartic acid can also be added to the water, or another fluid with a freezing point near 0 °C, to reduce the chance of supercooling in the tissue.
- Freezing can additionally be encouraged by applying a carrier at the interface, such as a saturated piece of gauze or another woven or non-woven material.
- the carrier should occupy some volume, but allow the free transfer of water across it. This carrier will ensure a sufficiently large and uniform quantity of water or other fluid is present at the interface which facilitates freezing of the skin.
- Supercooling can be minimized by presenting a seed crystal which serves as a nucleation source for water at or just below its freezing point.
- a seed crystal which serves as a nucleation source for water at or just below its freezing point.
- One of the best seed crystals is frozen water, or ice.
- the surface roughness of the applicator surface can be increased.
- the surface area of the applicator is increased and recessed areas will retain ice crystals even after being cleaned with alcohol or other cleaners. In addition these recessed areas prevent the ice from melting when first applied to warm skin.
- the applicator surface may be helpful to allow the applicator surface to dwell at a temperature below freezing for a period of time prior to the treatment to ensure water from the air freezes on its surface. Alternately it can be sprayed with a mist of water or other liquid, which will freeze on its surface prior to the treatment.
- Other mechanisms to trigger ice nucleation in a supercooled medium include vibration or other mechanical perturbations, and ultrasound or acoustic irradiation.
- the design of the cooler may include a vibrating element to induce freezing at some point in the cooling cycle.
- Ultrasound or acoustic transducers may also be incorporated in the system design to control the nucleation event.
- the epidermis is generally impervious to water, although there are specialized areas such as sweat glands that are specifically designed to control the flow of moisture across this barrier. It may be however that ice propagation is limited across the epidermis as the skin is cooled which could result in supercooling in the tissue. To prevent this, small holes can be made in the epidermis to allow ice to freely propagate across this barrier. Holes can be initiated by abrasions with a rough cloth or brush, with a microderm abrasion roller or system, with a laser, or with a number of additional techniques. Further details of methods and devices for controlling aspects of the interface between the cooling applicator and the skin are described in U.S. Patent Application 15/257,827, the entire contents of which were previously incorporated by reference, and which may be used with aspects of the disclosure described herein.
- FIG. 1 illustrates an exemplary treatment method 100 according to some embodiments.
- the method 100 may include modifying the skin of the patient in a manner described in U.S. Patent Application 15/257,827, previously incorporated by reference.
- the method 100 may start by placing small holes in the skin.
- a 0.3 mm, a 0.25 mm, or a 0.5 mm dermaroller may be used to place small holes in the epidermis. This may allow the subsequently generated ice to freely propagate across the stratum corneum. In prior studies, the stratum corneum appeared to create a barrier to ice propagation and although freezing occurred at the interface, the skin would freeze at a variable and unpredictable times even with consistent treatment conditions.
- the method 100 may further include pre-cooling a cooling applicator to a pretreatment temperature prior to contact of the cooling applicator with a skin surface of the patient 102.
- the applicator may be placed onto the skin of the patient 103.
- the cooling applicator may be driven toward the pre- treatment temperature for a first duration of time to pre-condition the skin to freeze 104.
- the temperature of the cooling applicator may be adjusted toward the treatment temperature for a second duration of time 106.
- the temperature of the cooling applicator may be adjusted toward a post-treatment temperature so as to thaw the frozen skin tissue 108. Thereafter, the cooling applicator may be removed from the skin of the patient after the interface between the cooling applicator and the skin thaws 110. [0059] It has been found that by initially applying a colder temperature, therefore setting up a larger temperature gradient between the cooler and the skin, the skin can be made to freeze more consistently. With other conditions being equal, applying a colder temperature of -5 °C to the skin will cause freezing more consistently over a shorter period of time than applying a temperature of -2 °C.
- a temperature of -10 °C will freeze more consistently and more quickly than a temperature of -5 °C and a temperature of -20 °C will freeze more consistently and more quickly than a temperature of -10 °C. While colder temperatures will freeze skin more consistently and more quickly, it may not be desirable to apply such a low temperature to the skin for the duration of the treatment as lower temperatures and/or longer durations may lead to increased adverse side effects, such as hyperpigmentation. Therefore, the cooler may be applied at a first colder temperature (or a pre-treatment or pre-conditioning temperature) to trigger freezing and then may be adjusted to a higher/warmer temperature that is still below the freezing point of the skin tissue for the duration of the treatment.
- ice crystal formation on the cooling applicator through moisture in the air or through water application directly to the cooling applicator (e.g., misting or the like) may be provided. Further, with colder precooling temperatures, it will be less likely that ice crystals that have formed on the surface of the applicator melt when the applicator is placed in contact with the patient skin. Accordingly, ice formation on the cooling applicator may remain after initial contact with the patient skin to seed ice formation at the interface and into the skin.
- the ice formed on the cooling applicator may melt upon the initial contact between the applicator and the skin and may be unavailable to seed ice formation at the interface and into the skin. Instead the water may return to and stay in the liquid state and may supercool for some variable amount of time, thereby reducing the consistency of freezing.
- the cooling applicator is pre-cooled 102 to a temperature between -10 °C and -20 °C.
- the cooling applicator is pre-cooled 102 to between - 12 °C and -18 °C, for example -15 °C.
- the cooling applicator is pre- cooled 102 to a temperature of -15 °C or colder.
- the temperature of the cooling applicator may increase due to heat transfer from the skin of the patient.
- the cooling applicator is driven toward the pre-treatment temperature for a duration of time after the initial contact 104.
- the duration of time where the cooling applicator is driven toward the pre-treatment temperature may be less than five seconds in some embodiments (e.g., 0-3 seconds or the like).
- the duration of time may be a preset parameter of a preprogrammed treatment cycle.
- the colder pre-treatment temperature may provide the larger temperature gradient between the cooling applicator and the skin and may thereby condition the skin to freeze in a more consistent manner and/or maintain previously seeded ice crystals at the interface between the cooling applicator and the skin.
- the thermal effusivity of the interface material and the applicator material may come into play here. If the applicator has a high thermal effusivity relative to the interface, its temperature may remain relatively stable (e.g. it doesn’t warm much) and therefore it is able to initiate freezing because any small ice crystals that have formed on its surface may stay frozen.
- the thickness of the applicator material also comes into play. A thick material of a high thermal effusivity maintains a relatively constant temperature, whereas a thin material backed by another material of a lower thermal effusivity would warm
- the applicator may comprise an aluminum surface having an approximately 0.5 inch thickness.
- the applicator may have a cooling surface with a thickness of 0.25 inches or less combined with a more powerful TEC that is able to respond to high transient heat loads.
- the cold plate may also be made out of copper or another material with a suitably high thermal effusivity.
- the applicator After the applicator is applied, it is driven toward the pretreatment temperature for a short period of time to ensure sufficient energy is extracted from the interface to initiate freezing then the applicator may be adjusted or warmed to a second temperature (or treatment temperature) 106, warmer than the first temperature.
- the treatment temperature while warmer than the pre-treatment temperature, is preferably below a skin freezing temperature, at least in certain embodiments.
- the treatment temperature is between -2 °C to -12 °C, or between -2 °C and -10 °C, for example -8 °C to -10 °C.
- the second warmer treatment temperature allows the treatment effect to be modulated (the warmer the temperature the less the effect) and reduce side effects (more prevalent at colder
- the applicator may then be driven toward the second temperature for a period of time sufficient to achieve the desired treatment effect but avoid undesired side effects.
- the temperature of the cooling applicator may be adjusted toward the treatment temperature for a duration between 10-30 seconds while the applicator is positioned against the skin.
- the duration of applying the second treatment temperature may be a preset parameter of a preprogrammed treatment cycle.
- the duration of time where the cooling applicator is driven toward the treatment temperature may be a predetermined parameter that is programmed into a preset treatment cycle.
- the duration of time where the cooling applicator is driven toward the treatment temperature may be variable and may, in certain embodiments, depend on the initiation of a skin freeze.
- a sensor may be incorporated to detect a freezing of a tissue proximal to the applicator. After the freeze is detected, the more moderate (warmer) second freezing temperature may be applied for a preset duration of time following the detection of the freeze. Such an embodiment may modulate the treatment effect by maintaining the tissue in the frozen state for a pre-specified duration of time.
- the freeze detection sensor may be a temperature sensor that is configured to detect the occurrence of local tissue freezing.
- the temperature detected by a temperature sensor may correspond to the temperature of the cooling applicator that it is in contact with.
- the detected temperature will rise as the bottom surface of the applicator is warmed slightly by the skin.
- the measured temperature will then decrease. The rate and extent of such decrease can depend on several factors, e.g., the initial temperature, material, and geometry of the applicator, the efficiency of the cooling arrangement used to cool the applicator, etc.
- the duration of time where the cooling applicator is driven toward the pre-treatment temperature after initial contact may be variable and may, in certain embodiments, depend on the initiation of a skin freeze.
- the freeze detection sensor may be incorporated to detect the freezing of the tissue proximal to the applicator. After the freeze is detected, the cooling applicator may cease to be driven toward the pre- treatment temperature and the more moderate (warmer) second freezing temperature may be applied thereafter.
- the temperature of the cooling applicator may be adjusted toward a post-treatment temperature 108.
- the post treatment temperature stops treatment and may be above 0 °C to thaw the interface or otherwise unstick the cooling applicator from the skin.
- the post- treatment temperature is between 0 °C and 10 °C (e.g., 5 °C or the like), or between 0 °C to 40 °C.
- the applicator may be maintained against the skin of the patient for upwards of 30 seconds after the treatment. After the interface thaws, the applicator may be removed from the skin 110. It should be understood that the times and temperatures are not critical. In some embodiments, the goal is to unfreeze the tissue in a relatively short period of time and to release the applicator from the tissue.
- FIG. 2 illustrates an exemplary cross-sectional side view of an exemplary apparatus 10 that can be used to produce hypopigmentation in a skin tissue according to some embodiments of the present invention.
- the exemplary apparatus 10 can include a cooling applicator 11 provided in a thermal communication with a thermoelectric cooler 12.
- a heat exchanger 16 may be thermally coupled with the thermoelectric cooler 12 on a side opposite from the cooling applicator 11.
- the cooling applicator 11 and the cooling arrangement 12 can be formed at least in part from a single material.
- a controller 15 can be provided and used to control certain aspects of the thermoelectric cooler 12, e.g., temperature, timed shutoff, etc., to perform aspects of method 100.
- the exemplary apparatus 10 can include a cooling applicator 11 provided in a thermal communication with a thermoelectric cooler 12.
- a heat exchanger 16 may be thermally coupled with the thermoelectric cooler 12 on a side opposite from the cooling applicator 11.
- the cooling applicator 11 and the cooling arrangement 12 can be formed at least in part from
- thermoelectric cooler 12, controller 15, and/or cooling applicator 11 can optionally be provided within or affixed to a housing or handpiece 13, as shown in Figure 2, e.g., to facilitate handling and positioning of the apparatus 10.
- the exemplary apparatus 10 shown in Figure 2 is not necessarily drawn to scale.
- the relative dimensions of the thermoelectric cooler 12 and cooling applicator 11 are not limited to the proportions illustrated in the Figure 2.
- the cooling applicator 11 can be larger or smaller in width or cross-sectional area as compared to the dimensions of the thermoelectric cooler 12.
- the cooling applicator 11 can include a distal (contact) surface 14 that is configured to contact a skin surface.
- the distal surface 14 can be substantially flat.
- the distal surface 14 can be convex or concave to better match the local shape of skin tissue being treated and/or to provide good thermal contact with the skin surface when the apparatus 10 is placed on the area of the skin to be treated.
- the cooling applicator 11 can be detachable from the thermoelectric cooler 12, e.g., so that a plurality of cooling applicator 11 having different sizes, shapes, and/or surface features as described herein can be used with a single thermoelectric cooler 12.
- the distal contact surface 14 can have a large width or diameter configured to contact the surface of a region of skin, e.g., a diameter or width that is greater than about 3-10 cm, or greater than about 5 cm, to facilitate treatment of large areas of skin.
- the width of the distal surface 14 can be small, e.g., on the order of 1-2 cm or less which may facilitate improved temperature control and/or treatment of particular features on the skin.
- the cooling applicator 11 can be formed from a metal or a metal alloy, or another material having a high thermal effusivity, e.g., such that values of these thermophysical properties are greater than the corresponding values for skin tissue.
- the thermal effusivity ⁇ is equal to the square root of the product of a material's thermal conductivity and its volumetric heat capacity.
- the thermal effusivity is a measure of the ability of a material to exchange heat with its surroundings and to maintain a consistent temperature as it does so.
- the cooling applicator 11, at least in part or wholly can be made of brass, copper, silver, aluminum, an aluminum alloy, steel, graphite, diamond, diamond-like carbon, other materials which are used in conventional contact cryoprobes, or combinations thereof.
- the cooling applicator 11 can be formed, wholly or at least in part, from materials having a much higher thermal conductivity than the skin tissue, and can be used to facilitate an extraction of heat from the portion of the tissue contacted by the distal surface 14 of the cooling applicator 11.
- materials having a much higher thermal effusivity than the skin tissue e.g. at least about 10 times the thermal effusivity of skin can be more readily maintained at a cold temperature.
- Such high-effusivity materials thereby may extract heat more effectively from the portion of tissue contacted by the cooling applicator 11 than materials having lower thermal effusivities, and facilitate a better control of the tissue temperature at a contact interface.
- the distal contact surface 14 of the cooling applicator 11 can be smaller in area than the proximal end of the cooling applicator 11 that contacts the thermoelectric cooler 12.
- Such geometry can provide certain advantages.
- the narrower or tapered distal end of the cooling applicator 11 can facilitate a more precise placement of the distal surface 14 on a particular location of the skin surface to be cooled, e.g., while reducing visual obstruction by the housing 13.
- the relatively larger proximal end of the cooling applicator 11 can provide a larger area that can be directly cooled by the thermoelectric cooler 12 to facilitate increased extraction of heat from the smaller distal contact surface 14.
- the area of the proximal end of the cooling applicator 11 can be at least twice as large as the area of the distal contact surface 14, e.g., 3-5 times as large.
- the distal surface 14 of the cooling applicator 11 can be provided with a plurality of protrusions, similar to those described in U.S. Patent Publication 2011/0313411 or U.S. Patent Pub.2014/0303697, previously incorporated by reference.
- Figures 2A and 2B illustrate exemplary treatment devices with protrusions 17 for discontinuous treatment of a region of skin which may provide cooling treatments according to the present disclosure.
- the distal surface may be flat or rounded to provide a continuous contact surface similar to the applicators described in U.S. Patent Publication 2014/0303696.
- Figure 2C illustrates an exemplary treatment device with a flat surface for continuous contact and treatment of a region of skin which may provide cooling treatments according to the present disclosure.
- the distal surface 14 may include dimples similar to the applicators described in U.S. Patent Publication 2015/0223975.
- Figure 2D illustrates an exemplary treatment device with a dimpled surface 21 for treatment of a region of skin which may provide cooling treatments according to the present disclosure.
- the distal surface 14 may be roughened or knurled similar to the applicators described in U.S. Provisional Patent Application
- Figure 2E illustrates an exemplary treatment device with a roughened surface for treatment of a region of skin which may provide cooling treatments according to the present disclosure.
- a controller 15 may be provided to control the thermoelectric cooler 12.
- Figure 3 illustrates an exemplary method 300 for delivering treatment cycles according to some embodiments.
- the controller 15 may be configured to control the thermoelectric cooler 12 or other cooling arrangement to provide a cooling treatment cycle that performs certain aspects of method 100.
- the controller 15 may deliver a first electrical current to the thermoelectric cooler 12 to pre-cool the cooling applicator 11 to a pre-treatment temperature prior to contact with the skin of the patient 302.
- the first electrical current may be delivered to the thermoelectric cooler 12 to cool the cooling applicator toward the pre-treatment temperature for a first duration of time after the cooling applicator is placed against the skin of the patient 302.
- a second electrical current may be delivered to the thermoelectric cooler 12 to adjust the temperature of the cooling applicator 11 toward a treatment temperature that is higher (warmer but generally below a temperature for skin freezing) than the pre-treatment temperature for a second duration of time 304.
- a third electrical current may be delivered to the thermoelectric cooler 12 to adjust the temperature of the cooling applicator 11 toward a post-treatment temperature that is higher than the treatment temperature for a third duration of time 306.
- a temperature sensor may be provided to provide a signal to the controller 15 that is associated with a temperature of the cooling applicator 11.
- the signal from the temperature sensor may indicate when the cooling applicator 11 has reached the pre-treatment temperature and is ready for application to the skin of the patient.
- the controller 15 may provide a user perceptible signal to indicate that the device 10 is ready for application to the skin of the patient.
- the user perceptible signal may be audio, visual, or haptic or the like.
- the controller 15 may also, in response to the temperature signal, automatically adjust the current and/or power delivered to the thermoelectric cooler 12 to drive the cooling applicator toward the desired temperature.
- the current delivered to the thermoelectric cooler may be temporarily reversed during transition from the delivery of the first electrical current to the delivery of the second electrical current.
- the current delivered to the thermoelectrical cooler may be temporarily reversed during transition from the delivery of the second electrical current to the delivery of the third electrical current.
- the power delivered to the thermoelectric cooler may be reduced or turned off during transition from the delivery of the first electrical current to the delivery of the second electrical current.
- the power delivered to the thermoelectric cooler may be reduced or turned off during transition from the delivery of the second electrical current to the delivery of the third electrical current.
- the adjustments to the thermoelectric cooler 12 after the first duration of time and the second duration of time may be automatic as well.
- a user may actuate a switch when the cooling applicator is applied against the skin of a patient. Actuation of the switch may signal the start of a treatment cycle to the controller 15.
- controller 15 may adjust the current and/or power delivered to the
- thermoelectric cooler 12 in a preprogrammed manner to adjust the temperatures at the preset times.
- a contact sensor may be provided that provides a signal to the controller 15 that indicates that the cooling applicator 11 is placed against the skin of the patient. Thereafter, the controller 15 may automatically initiate a cooling treatment cycle (e.g., where the controller 15 automatically adjusts temperatures in which the cooling arrangement 12 is driven toward after the first and second durations of time).
- the contact sensor may be a force sensor, optical sensor, IR sensor, temperature sensor, or a sensor that measures a change in the electrical properties of the plate and interface such as a change in resistance, capacitance, or the like.
- a temperature sensor may be provided.
- the treatment cycle may be initiated when the temperature sensor detects an increase in temperature from the pre-treatment temperature.
- the increase in temperature may be due to contact with the skin of the patient and heat transfer from the skin into the cooling plate. Thereafter, the treatment cycle may be triggered (e.g., automatically) by the increase in temperature.
- the temperature signal from the sensor may be averaged over a duration of time (e.g., 1-2 seconds) or moving time window, and then compared to the threshold. This may help reduce unintended triggers due to transient drops or spikes in temperatures sensed.
- a force sensor may be provided that detects when the cooling applicator is contacted with the skin based on a force experienced at the cooling applicator.
- An increase in force sensed may indicate that the applicator is being pressed against the skin of the patient. Thereafter, the treatment cycle may be triggered (e.g., automatically) by the increase in force sensed.
- a negative force sensed may indicate that the applicator is still frozen/attached to the patient skin during an inadvertent device removal. A warning to the end user could then be triggered to prevent potential damage to the patient skin.
- the force signal from the sensor may be averaged over a duration of time (e.g., 1-2 seconds) or moving time window, and then compared to the threshold. This may help reduce unintended triggers due to transient drops or spikes in forces sensed.
- the initial contact of the cooling apparatus with the skin may also be detected based on a change in the amount of power delivered to a thermoelectric cooler. For example, when the apparatus makes initial contact with the skin of the patient, a temperature of the thermoelectric cooler may increase due to heat transfer from the skin of the patient.
- the controller 15, using temperature feedback may deliver additional power to the thermoelectric cooler to maintain the thermoelectric cooler at a desired temperature.
- the increase in power delivered to the thermoelectric cooler may trigger the initiation of the treatment cycle.
- the contact may be detected by observing a change in the measured temperature of the cold plate.
- the treatment may be triggered by a mechanical switch that is user actuated when the applicator is placed in contact with the skin. Accordingly, one or more signals from contact sensors, power consumption measurements, heat flux measurements, or other measured signals may also modify treatment parameters/algorithm during treatment.
- the treatment device may be provided with one or more force sensors, as shown in the exemplary cross-sectional configuration of Figure 4.
- the exemplary apparatus 400 can include a handle 402, a cooling arrangement 420, and an optional cooling plate 422 provided on a lower surface of a cooling arrangement 420.
- the force sensor(s) 410 can be used to detect force which may be translated into a pressure based on the application surface size of the cold plate thereby communicating, e.g., a contact pressure between the contact surface 440 of the apparatus 400 and the skin or tissue surface during operation of the apparatus 400.
- Such pressure detection can be useful, e.g., to ensure a sufficient or appropriate pressure is applied to facilitate good thermal contact between the contact element 422 and the tissue being treated.
- a contact pressure of a few PSI or more can also produce some local blanching or restriction of blood flow near the tissue surface. Local blanching can reduce the heat transfer to the local tissue by flowing blood, and thereby improve the cooling or heat extraction by the apparatus 400 near the tissue or skin surface.
- the force sensor(s) 410 can include any conventional components that can be used to detect force such as, e.g., a piezoelectric material, a piezoresistive strain gauge, a capacitive or inductive sensor, pressure sensitive inks, etc.
- One or more force sensors 410 can be provided in the apparatus 400. Their number, type and/or locations of the force sensors 410 can be selected based on several factors including, e.g., reliability of the detected contact force. For example, the force sensor 410 can be small, have a low thermal mass and/or have a high thermal conductivity to minimize or avoid any reduction in the heat transfer characteristics of the apparatus 400.
- the location of the one or more force sensors 410 can be selected to provide an accurate indication of the contact pressure between the contact surface 440 and the skin surface during use of the apparatus 400.
- one or more force sensors 410 can be provided between an upper portion of the cooling arrangement 420 and the handle 402, as shown in Figure 4, if the cooling arrangement 420 and handle 402 are in good mechanical contact.
- This exemplary configuration can provide force sensing capabilities while avoiding any reduction of the heat flow or transfer between the cooling arrangement 420 and the skin surface.
- one or more force sensors 410 can be provided between the cooling arrangement 420 and the contact element 422, on the contact surface 440 of the contact element 422, within the contact element 422, or any combination of such locations.
- a force indicator 460 can be provided on or near the apparatus 400.
- Such force indicator can include a digital or analog readout of the detected contact force , an indicator light that can turn on/off or change color to indicate when the contact force is within or outside a particular force range or above/below a particular limit, an audible signal, etc.
- the force indicator can be used to provide or otherwise transmit a signal to the operator to ensure the presence of an appropriate contact force during use of the apparatus 400. This force -sensing feature can be used with any of the exemplary embodiments of the apparatus and method described herein.
- the force sensor 410 may be coupled with the controller 450 and the duration of time where the cooling applicator is driven toward the pre- treatment and/or treatment temperature may be automatically modulated based on the force sensed by force sensor 410. For example, if the force sensor 410 senses a force below a certain threshold, a duration of time where the cooling applicator is driven toward the pre- treatment and/or treatment temperature may be adjusted (prolonged or adjusted). Similarly, if the force sensor 410 senses a force above a certain threshold, a duration of time where the cooling applicator is driven toward the pre-treatment and/or treatment temperature may be adjusted (e.g., prolonged or shortened).
- the force will be normalized by the surface area of the contact surface resulting in a pressure.
- a timer for the pre-treatment time or the treatment time may be paused when the pressure sensed is below the threshold and restarted when the pressure sensed rises above the threshold.
- the timer for the pre-treatment time or the treatment time may be reset if the pressure sensed falls below the threshold.
- the treatment time may be extended if the pressure drops below a threshold, for example 1 psi. Additionally, the treatment time may be extended if the pressure exceeds a threshold.
- a temperature of the cooling applicator may be adjusted. For example, in some embodiments, if the force sensor 410 senses a force below a threshold, controller 450 may adjust the cooling arrangement to deliver a colder temperature (during pre-treatment and/or treatment). Additionally, in some embodiments, if the force sensor 410 senses a force above a threshold, controller 450 may adjust the cooling arrangement to deliver a warmer temperature (during pre-treatment and/or treatment). In some embodiments, the signal from the sensor may be averaged over a duration of time (e.g., 1-2 seconds) or moving time window, and then compared to the threshold.
- a duration of time e.g., 1-2 seconds
- feedback from force sensor 410 may signal the end of a treatment cycle.
- a pressure drop may be detected by force sensor 410, e.g., sensing a transition from 2-5 lbs. to about 0 lbs., which signals that the user (clinician or the like) has removed the apparatus from the skin of the patient.
- the controller 450 may reset the apparatus to a desired state or idle state. For example, in some
- the controller 450 may control the cooling arrangement 420 to drive the contact surface 422 toward the pre-treatment temperature to prepare for the next cooling treatment application. Alternatively, in some embodiments, the controller 450 may cease power delivery to the cooling arrangement 420 when the force sensor 410 indicates that the contact surface 422 has been disengaged from the skin of the patient. While several aspects above have been generally described with use of a force sensor 410, it will be appreciated that other contact sensors or measured signals (e.g., heat flux measurement) may be used as discussed above. For example, spring-based contact sensor, infrared contact sensors, or the like may be used to sense the disengagement of the contact surface 422 from the skin of the patient so as to automatically trigger the return of the apparatus to a desired or idle state.
- an accelerometer or other orientation sensor 470 may be provided to sense an orientation of the apparatus 400 to adjust for the gravitational or orientational effects to ensure that the controller 450 accurately determines when the apparatus is removed from the skin of the patient.
- the controller coupled with multiple force sensors may be configured to determine when the apparatus is applied to the skin at an improper tilt or angle during a treatment cycle.
- the precooling duration/temperature and/or treatment duration/temperature may be adjusted to account for the improper tilt of the apparatus relative to the skin.
- the signal from the orientation sensor may be averaged over a duration of time (e.g., 1-2 seconds) and then compared to the tilt threshold.
- FIG. 5 illustrates another exemplary treatment method 500 according to some embodiments of the present invention.
- the method 500 may start with placing a cooling applicator onto the skin of the patient 502.
- the skin of the patient may then be intentionally supercooled with the cooling applicator 504.
- a freeze of the skin may be initiated with a vibrator 506.
- the cooling applicator may be maintained against the skin surface for a first duration of time after freeze initiation 508.
- the temperature of the cooling applicator may be adjusted toward a post-treatment temperature so as to thaw the frozen skin tissue 510.
- the cooling applicator may be removed from the skin of the patient 512.
- the skin might be supercooled for 20 seconds prior to inducing crystallization in the tissue.
- the tissue might then be held in the frozen state for an additional 15 seconds before rewarming to thaw the tissue.
- the structure of the ice crystals change depending on the level of supercooling.
- the crystallization happens more rapidly in supercooled tissue. Both the structure and the speed of formation of ice crystals in the skin may lead to a beneficial clinical outcome when induced in supercooled tissue.
- the treatment becomes more controllable and consistent.
- FIG. 6 illustrates an exemplary cooling apparatus 600 that can be used to produce hypopigmentation in skin tissue according to method 500.
- the exemplary apparatus 600 can include a cooling applicator 611 provided in a thermal communication with a thermoelectric cooler 612.
- a heat exchanger 616 may be thermally coupled with the thermoelectric cooler 612 on a side opposite from the cooling applicator 611.
- the cooling applicator 611 and the cooling arrangement 612 can be formed at least in part from a single material.
- a vibrator 618 e.g., acoustic transducer, ultrasound transducer, or the like
- the vibrator 618 may be coupled with a distal side of the heat exchanger 616 so that the vibrator 618 is on the opposite side of the heat exchanger 616 relative to the thermal electric cooler.
- a controller 615 can be provided and used to control certain aspects of the thermoelectric cooler 612, e.g., temperature, etc.
- controller 615 may be coupled with the vibrator 618 to control the delivery (e.g., timing, power, frequency, etc.) of the ultrasound from the vibrator 618.
- the thermoelectric cooler 612, controller 615, vibrator 618, and/or cooling applicator 611 can optionally be provided within or affixed to a housing or handpiece 613, as shown in Figure 6, e.g., to facilitate handling and positioning of the apparatus 600.
- the exemplary apparatus 600 shown in Figure 6 is not necessarily drawn to scale.
- thermoelectric cooler 612 and cooling applicator 611 are not limited to the proportions illustrated in the Figure 6.
- the cooling applicator 611 can be larger or smaller in width or cross-sectional area as compared to the dimensions of the thermoelectric cooler 612.
- the cooling applicator 611 can include a distal (contact) surface 614 that is configured to contact a skin surface.
- the distal surface 614 can be substantially flat.
- the distal surface 614 can be convex or concave to better match the local shape of skin tissue being treated and/or to provide good thermal contact with the skin surface when the apparatus 600 is placed on the area of the skin to be treated.
- the cooling applicator 611 can be detachable from the thermoelectric cooler 612, e.g., so that a plurality of cooling applicator 611 having different sizes, shapes, and/or surface features as described herein can be used with a single thermoelectric cooler 612.
- the distal contact surface 614 can have a large width or diameter configured to contact the surface of a region of skin, e.g., a diameter or width that is greater than about 3-10 cm, or greater than about 5 cm, to facilitate treatment of large areas of skin.
- the width of the distal surface 614 can be small, e.g., on the order of 1-2 cm or less which may facilitate improved temperature control and/or treatment of particular features on the skin.
- the cooling apparatus 600 may be configured to intentionally supercool the skin of the patient 504 for a period after initial contact with the skin of the patient.
- the cooling apparatus 600 may supercool the skin by gradually cooling the target surface to a first temperature, which could be between 0-5 °C or between 5-10 °C. Possibly, after the freezing is initiated, the tissue could be warmed to a warmer temperature, still below the freezing point of tissue.
- a freeze of the skin may be initiated with a vibrator 506.
- the vibrations or other kinds of mechanical perturbations may help trigger or otherwise facilitate or promote ice nucleation in the fluid medium and/or the skin of the patient.
- the vibrator 618 may include one or more acoustic or ultrasound transducers (piezo elements or the like).
- the ultrasound transducer may deliver acoustic energy in the 20– 100 kHz range.
- the vibrator 618 may be an electrical motor with an unbalanced mass on its drive shaft. While method 500 may be performed with device 600 which has an integrated vibrator 618, it should be understood that method 500 may be performed with a cooling apparatus and a separate vibration device in other embodiments of the present invention.
- the cooling applicator 600 may be maintained against the skin surface for a first duration of time after freeze initiation 508.
- the cooling applicator 600 may be driven towards a treatment temperature during the first duration of time.
- the treatment temperature may be below a skin freezing temperature, at least in certain embodiments.
- the treatment temperature is between -2 °C to -12 °C , or between -2 °C and -10 °C, for example -8 °C to -10 °C.
- the cooling applicator 600 may be driven toward the treatment temperature for duration between 10-30 seconds while the applicator 600 is positioned against the skin.
- the duration of applying the treatment temperature may be a preset parameter of a
- the duration of time may be variable and may be reset or paused based on signals from sensors (e.g., contact sensor, orientation sensor) or other measured signals similar to the embodiments described above.
- sensors e.g., contact sensor, orientation sensor
- the temperature of the cooling applicator may be adjusted toward a post-treatment temperature so as to thaw the frozen skin tissue 510.
- the post treatment temperature stops treatment and may be above 0 °C to thaw the interface or otherwise unstick the cooling applicator from the skin.
- the post- treatment temperature is between 0 °C and 10 °C (e.g., 5 °C or the like), or between 0 °C to 40 °C.
- the applicator may be maintained against the skin of the patient for upwards of 30 seconds after the treatment.
- the cooling applicator may be removed from the skin of the patient 512. It should be understood that the times and temperatures are not critical. In some embodiments, the goal is to unfreeze the tissue in a relatively short period of time and to release the applicator from the tissue.
- One or more computing devices may be adapted to provide desired functionality by accessing software instructions rendered in a computer-readable form.
- any suitable programming, scripting, or other type of language or combinations of languages may be used to implement the teachings contained herein.
- software need not be used exclusively, or at all.
- some embodiments of the methods and systems set forth herein may also be implemented by hard-wired logic or other circuitry, including but not limited to application-specific circuits. Combinations of computer- executed software and hard-wired logic or other circuitry may be suitable as well.
- Embodiments of the methods disclosed herein may be executed by one or more suitable computing devices.
- Such system(s) may comprise one or more computing devices adapted to perform one or more embodiments of the methods disclosed herein.
- such devices may access one or more computer -readable media that embody computer-readable instructions which, when executed by at least one computer, cause the at least one computer to implement one or more embodiments of the methods of the present subject matter.
- the computing device(s) may comprise circuitry that renders the device(s) operative to implement one or more of the methods of the present subject matter.
- Any suitable computer-readable medium or media may be used to implement or practice the presently-disclosed subject matter, including but not limited to, diskettes, drives, and other magnetic-based storage media, optical storage media, including disks (e.g., CD- ROMS, DVD-ROMS, variants thereof, etc.), flash, RAM, ROM, and other memory devices, and the like.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Percussion Or Vibration Massage (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020187037943A KR102448859B1 (ko) | 2016-06-03 | 2017-06-02 | 피부 처리를 위한 냉각 시스템 및 방법 |
CN201780033506.4A CN109310460B (zh) | 2016-06-03 | 2017-06-02 | 冷却系统和皮肤处理方法 |
EP17807609.7A EP3463132A4 (en) | 2016-06-03 | 2017-06-02 | COOLING SYSTEMS AND METHODS FOR SKIN TREATMENT |
JP2018562999A JP6975178B2 (ja) | 2016-06-03 | 2017-06-02 | 皮膚治療のための冷却システムおよび方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662345303P | 2016-06-03 | 2016-06-03 | |
US62/345,303 | 2016-06-03 | ||
US201662430782P | 2016-12-06 | 2016-12-06 | |
US62/430,782 | 2016-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017210619A1 true WO2017210619A1 (en) | 2017-12-07 |
Family
ID=60477907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2017/035791 WO2017210619A1 (en) | 2016-06-03 | 2017-06-02 | Cooling systems and methods for skin treatment |
Country Status (6)
Country | Link |
---|---|
US (2) | US11266524B2 (ja) |
EP (1) | EP3463132A4 (ja) |
JP (1) | JP6975178B2 (ja) |
KR (1) | KR102448859B1 (ja) |
CN (1) | CN109310460B (ja) |
WO (1) | WO2017210619A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113260460A (zh) * | 2018-12-21 | 2021-08-13 | R2科技公司 | 用于皮肤病学冷冻喷雾装置的自动控制和定位系统 |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102012013534B3 (de) | 2012-07-05 | 2013-09-19 | Tobias Sokolowski | Vorrichtung für repetitive Nervenstimulation zum Abbau von Fettgewebe mittels induktiver Magnetfelder |
US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
US10478633B2 (en) | 2015-07-01 | 2019-11-19 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10471269B1 (en) | 2015-07-01 | 2019-11-12 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10695576B2 (en) | 2015-07-01 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10821295B1 (en) | 2015-07-01 | 2020-11-03 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US20180001107A1 (en) | 2016-07-01 | 2018-01-04 | Btl Holdings Limited | Aesthetic method of biological structure treatment by magnetic field |
US11266850B2 (en) | 2015-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
US10695575B1 (en) | 2016-05-10 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10709894B2 (en) | 2015-07-01 | 2020-07-14 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US10709895B2 (en) | 2016-05-10 | 2020-07-14 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10583287B2 (en) | 2016-05-23 | 2020-03-10 | Btl Medical Technologies S.R.O. | Systems and methods for tissue treatment |
US10556122B1 (en) | 2016-07-01 | 2020-02-11 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
KR20200024241A (ko) | 2017-06-30 | 2020-03-06 | 알2 더마톨로지, 인크. | 노즐들의 선형 어레이를 갖는 피부 과학적 냉동 스프레이 디바이스들 및 사용 방법들 |
DE102017116004A1 (de) * | 2017-07-17 | 2019-01-17 | Kuka Industries Gmbh | Roboter und Verfahren zum Behandeln von Flächen |
US20200060868A1 (en) * | 2017-12-01 | 2020-02-27 | Freeze N Fit Inc. | Cold treatment apparatus |
TW202023486A (zh) * | 2018-09-05 | 2020-07-01 | 德商得瑪法公司 | 用於治療疱疹疾病之裝置 |
CA3116569C (en) | 2019-04-11 | 2023-08-15 | Btl Medical Technologies S.R.O. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
USD895823S1 (en) | 2019-05-24 | 2020-09-08 | Church & Dwight Co., Inc. | Facial massaging device |
USD905262S1 (en) | 2019-05-24 | 2020-12-15 | Church & Dwight Co., Inc. | Facial massaging device |
KR102352145B1 (ko) * | 2020-01-03 | 2022-01-17 | 구본철 | 피부 미백 마스크, 피부 미백 기기 및 이를 이용하는 피부 미백 방법 |
KR102352140B1 (ko) * | 2020-01-03 | 2022-01-17 | 구본철 | 피부 미백 마스크, 피부 미백 기기 및 이를 이용하는 피부 미백 방법 |
KR102352150B1 (ko) * | 2020-01-03 | 2022-01-17 | 구본철 | 피부 미백 마스크, 피부 미백 기기 및 이를 이용하는 피부 미백 방법 |
US20220273088A1 (en) * | 2019-07-30 | 2022-09-01 | Boncheol GOO | Skin whitening mask, skin whitening device, and skin whitening method using same |
KR102200465B1 (ko) * | 2020-01-03 | 2021-01-08 | 구본철 | 피부 미백 마스크, 피부 미백 기기 및 이를 이용하는 피부 미백 방법 |
USD949380S1 (en) | 2020-01-08 | 2022-04-19 | Church & Dwight Co., Inc. | Facial massaging device |
CA3173876A1 (en) | 2020-05-04 | 2021-11-11 | Tomas SCHWARZ | Device and method for unattended treatment of a patient |
US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
US11278341B2 (en) * | 2020-07-14 | 2022-03-22 | Recensmedical, Inc. | Method of safely using controlled cooling systems and devices |
US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060282067A1 (en) * | 1999-07-29 | 2006-12-14 | Koop Dale E | Thermal quenching of tissue |
US20110313411A1 (en) * | 2008-08-07 | 2011-12-22 | The General Hospital Corporation | Method and apparatus for dermatological hypopigmentation |
US20140303696A1 (en) * | 2011-11-16 | 2014-10-09 | The General Hospital Corporation | Method and apparatus for cryogenic treatment of skin tissue |
US20150216720A1 (en) * | 2014-01-31 | 2015-08-06 | Zeltiq Aesthetics, Inc. | Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3664344A (en) | 1970-09-15 | 1972-05-23 | Brymill Corp | Tyned cryosurgical probe |
US4206609A (en) | 1978-09-01 | 1980-06-10 | Actus, Inc. | Cryogenic surgical apparatus and method |
JPH04133822A (ja) | 1990-09-21 | 1992-05-07 | Iseki & Co Ltd | 乗用トラクタの変速操作装置 |
DE9217897U1 (de) | 1992-12-31 | 1993-11-11 | Langenbeck Kurt | Gummiwärmflasche |
US5374284A (en) * | 1993-03-05 | 1994-12-20 | Guibert; Raul | Power control unit for thermotherapy applicator |
GB2283678B (en) | 1993-11-09 | 1998-06-03 | Spembly Medical Ltd | Cryosurgical catheter probe |
GB2286660A (en) | 1994-02-01 | 1995-08-23 | David Thorner | Peltier effect cooling apparatus for treating diseased or injured tissue |
US5848981A (en) | 1994-11-01 | 1998-12-15 | Herbranson; Larry W. | Method and apparatus for headache relief |
RU2074680C1 (ru) | 1995-05-10 | 1997-03-10 | Кузнецов Олег Федорович | Устройство для криотерапии |
US5901707A (en) | 1995-05-19 | 1999-05-11 | Hpl Biomedical, Inc. | Silicone mask for cryosurgery and method |
US5596875A (en) | 1995-08-10 | 1997-01-28 | Hughes Aircraft Co | Split stirling cycle cryogenic cooler with spring-assisted expander |
US7115123B2 (en) * | 1996-01-05 | 2006-10-03 | Thermage, Inc. | Handpiece with electrode and non-volatile memory |
JPH1052475A (ja) | 1996-08-13 | 1998-02-24 | Takeo Matsumoto | 冷灸用の施術器具 |
BE1010730A7 (nl) | 1996-11-04 | 1998-12-01 | Pira Luc Louis Marie Francis | Cryoprobe op basis van peltier module. |
US6503246B1 (en) | 2000-07-05 | 2003-01-07 | Mor Research Applications Ltd. | Cryoprobe and method of treating scars |
US6702808B1 (en) | 2000-09-28 | 2004-03-09 | Syneron Medical Ltd. | Device and method for treating skin |
US20080214988A1 (en) | 2000-12-28 | 2008-09-04 | Palomar Medical Technologies, Inc. | Methods And Devices For Fractional Ablation Of Tissue |
US6430956B1 (en) | 2001-05-15 | 2002-08-13 | Cimex Biotech Lc | Hand-held, heat sink cryoprobe, system for heat extraction thereof, and method therefore |
US6648904B2 (en) | 2001-11-29 | 2003-11-18 | Palomar Medical Technologies, Inc. | Method and apparatus for controlling the temperature of a surface |
US8840608B2 (en) | 2002-03-15 | 2014-09-23 | The General Hospital Corporation | Methods and devices for selective disruption of fatty tissue by controlled cooling |
CN101669841A (zh) | 2002-03-15 | 2010-03-17 | 总医院公司 | 通过受控冷却对脂肪组织进行选择性破坏的方法和装置 |
US20050085749A1 (en) | 2003-10-15 | 2005-04-21 | Kevin Baerwalde | Device for therapeutic treatment of foot, heel, and/or like pain |
US6981970B2 (en) | 2002-12-16 | 2006-01-03 | Msq (M2) Ltd. | Device and method for treating skin |
US7981111B2 (en) | 2003-02-25 | 2011-07-19 | Tria Beauty, Inc. | Method and apparatus for the treatment of benign pigmented lesions |
JP2005237908A (ja) | 2004-02-12 | 2005-09-08 | Tamotsu Nishizaki | 熱交換器を用いた冷凍手術器 |
WO2005096979A1 (en) | 2004-04-01 | 2005-10-20 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
US20060058238A1 (en) | 2004-09-15 | 2006-03-16 | Lee Laurent-Applegate | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
EP1650839A1 (en) | 2004-10-20 | 2006-04-26 | Wavelight Laser Technologie AG | Fiber laser arrangement |
ES2383376T3 (es) | 2005-01-18 | 2012-06-20 | Alma Lasers Ltd | Sistema mejorado para calentar tejido biológico mediante energía de RF |
US9215788B2 (en) | 2005-01-18 | 2015-12-15 | Alma Lasers Ltd. | System and method for treating biological tissue with a plasma gas discharge |
US7850683B2 (en) | 2005-05-20 | 2010-12-14 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US7713266B2 (en) | 2005-05-20 | 2010-05-11 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US7740645B2 (en) | 2005-10-18 | 2010-06-22 | Ab Ortho, Llc | Apparatus and method for treating soft tissue injuries |
US20070088386A1 (en) | 2005-10-18 | 2007-04-19 | Babaev Eilaz P | Apparatus and method for treatment of soft tissue injuries |
US20070142885A1 (en) | 2005-11-29 | 2007-06-21 | Reliant Technologies, Inc. | Method and Apparatus for Micro-Needle Array Electrode Treatment of Tissue |
US20070135876A1 (en) | 2005-12-08 | 2007-06-14 | Weber Paul J | Acne and skin defect treatment via non-radiofrequency electrical current controlled power delivery device and methods |
FR2894460A1 (fr) | 2005-12-09 | 2007-06-15 | Oreal | Procede de traitement cosmetique ou dermatologique et dispositifs pour la mise en oeuvre d'un tel procede |
WO2007099546A2 (en) | 2006-03-03 | 2007-09-07 | Alma Lasers Ltd. | Method and apparatus for light-based hair removal using incoherent light pulses |
EP1998700B1 (en) | 2006-03-03 | 2015-01-21 | Alma Lasers Ltd | Method for light-based hair removal |
KR200431404Y1 (ko) | 2006-08-16 | 2006-11-23 | 최훈섭 | 피부 치료 장치 |
US20080076958A1 (en) | 2006-09-21 | 2008-03-27 | Alma Lasers Ltd. | Method And Apparatus For Treating A Fungal Nail Infection With Shortwave And/Or Microwave Radiation |
US20080077201A1 (en) | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Cooling devices with flexible sensors |
EP1911410A1 (de) | 2006-10-10 | 2008-04-16 | Wavelight Aesthetic GmbH | Vorrichtung für dermatologische Behandlungen |
CA2667964A1 (en) | 2006-10-31 | 2008-05-08 | Zeltiq Aesthetics, Inc. | Method and apparatus for cooling subcutaneous lipid-rich cells or tissue |
US20080119839A1 (en) | 2006-11-21 | 2008-05-22 | Vancelette David W | Cryosurgical Applicator |
KR100802155B1 (ko) | 2006-12-06 | 2008-02-12 | 하지훈 | 피부치료용 마이크로니들 스탬프 |
WO2008091983A2 (en) | 2007-01-25 | 2008-07-31 | Thermage, Inc. | Treatment apparatus and methods for inducing microburn patterns in tissue |
US9283029B2 (en) | 2007-01-31 | 2016-03-15 | Alma Lasers Ltd. | Skin treatment using a multi-discharge applicator |
US8523927B2 (en) | 2007-07-13 | 2013-09-03 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
US20090171424A1 (en) | 2007-12-27 | 2009-07-02 | Alma Lasers Ltd. | Rf device for heating biological tissue using a vibrating applicator |
WO2009095894A2 (en) | 2008-02-01 | 2009-08-06 | Alma Lasers Ltd. | Apparatus and method for selective ultrasonic damage of adipocytes |
AU2009251688A1 (en) | 2008-04-01 | 2009-12-03 | The General Hospital Corporation | Method and apparatus for cooling biological tissue |
US8128617B2 (en) * | 2008-05-27 | 2012-03-06 | Boston Scientific Scimed, Inc. | Electrical mapping and cryo ablating with a balloon catheter |
US20100036295A1 (en) | 2008-08-08 | 2010-02-11 | Palomar Medical Technologies, Inc. | Method and apparatus for fractional deformation and treatment of cutaneous and subcutaneous tissue |
US20100161014A1 (en) | 2008-12-23 | 2010-06-24 | Lynch Joseph M | Thermal treatment device |
US9545284B2 (en) | 2009-04-30 | 2017-01-17 | Alma Lasers Ltd. | Devices and methods for dermatological treatment |
US8435194B2 (en) | 2009-07-12 | 2013-05-07 | Alma Lasers Ltd | Device for RF heating and mechanical massage of biological tissue |
WO2011013101A1 (en) | 2009-07-30 | 2011-02-03 | Alma Lasers Ltd. | A sonotrode |
US20120071794A1 (en) | 2010-09-20 | 2012-03-22 | Alma Lasers Ltd. | Robotic System for Delivering Energy for Treatment of Skin of a Subject |
EP2709726B1 (en) | 2011-05-19 | 2015-11-04 | Alma Lasers Ltd | Apparatus for concurrent treatment with ultrasonic energy and thermal rf energy |
US20120330194A1 (en) | 2011-05-19 | 2012-12-27 | Alexander Britva | Apparatus and method for treating tissue with ultrasound |
JP6046158B2 (ja) | 2011-11-16 | 2016-12-14 | ザ ジェネラル ホスピタル コーポレイション | 皮膚組織の低温処置のための方法及び装置 |
GB2497613B (en) | 2012-07-05 | 2013-11-20 | Alma Lasers Ltd | Ultrasonically excited comb |
WO2014164887A1 (en) * | 2013-03-12 | 2014-10-09 | Gentherm Incorporated | Devices, systems and methods of cooling the skin |
US9763827B2 (en) * | 2013-04-30 | 2017-09-19 | Tear Film Innovations, Inc. | Systems and methods for the treatment of eye conditions |
GB2516903A (en) | 2013-08-06 | 2015-02-11 | Alma Lasers Ltd | Electrode for a system for heating biological tissue via RF energy |
US20150080991A1 (en) | 2013-09-16 | 2015-03-19 | Alma Lasers Ltd. | Radio frequency treatment of sweat glands |
US9907692B2 (en) * | 2013-12-30 | 2018-03-06 | Zenith Technical Innovations, Llc | Therapeutic thermal compression device |
US20150223975A1 (en) * | 2014-02-12 | 2015-08-13 | The General Hospital Corporation | Method and apparatus for affecting pigmentation of tissue |
CN104490372A (zh) * | 2014-12-30 | 2015-04-08 | 续嘉 | 一种降温装置 |
US20160317346A1 (en) * | 2015-04-28 | 2016-11-03 | Zeltiq Aesthetics, Inc. | Systems and methods for monitoring cooling of skin and tissue to identify freeze events |
SG10202106186YA (en) * | 2015-06-03 | 2021-07-29 | Novopyxis Inc | Fluid delivery devices and methods |
WO2017041022A1 (en) | 2015-09-04 | 2017-03-09 | R2 Dermatology, Inc. | Medical systems, methods, and devices for hypopigmentation cooling treatments |
US11382790B2 (en) * | 2016-05-10 | 2022-07-12 | Zeltiq Aesthetics, Inc. | Skin freezing systems for treating acne and skin conditions |
WO2017196548A1 (en) * | 2016-05-10 | 2017-11-16 | Zeltiq Aesthetics, Inc. | Skin freezing systems for treating acne and skin conditions |
-
2017
- 2017-06-02 EP EP17807609.7A patent/EP3463132A4/en active Pending
- 2017-06-02 US US15/612,740 patent/US11266524B2/en active Active
- 2017-06-02 CN CN201780033506.4A patent/CN109310460B/zh active Active
- 2017-06-02 JP JP2018562999A patent/JP6975178B2/ja active Active
- 2017-06-02 WO PCT/US2017/035791 patent/WO2017210619A1/en unknown
- 2017-06-02 KR KR1020187037943A patent/KR102448859B1/ko active IP Right Grant
-
2022
- 2022-02-10 US US17/669,010 patent/US20220233345A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060282067A1 (en) * | 1999-07-29 | 2006-12-14 | Koop Dale E | Thermal quenching of tissue |
US20110313411A1 (en) * | 2008-08-07 | 2011-12-22 | The General Hospital Corporation | Method and apparatus for dermatological hypopigmentation |
US20140303696A1 (en) * | 2011-11-16 | 2014-10-09 | The General Hospital Corporation | Method and apparatus for cryogenic treatment of skin tissue |
US20150216720A1 (en) * | 2014-01-31 | 2015-08-06 | Zeltiq Aesthetics, Inc. | Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments |
Non-Patent Citations (1)
Title |
---|
See also references of EP3463132A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113260460A (zh) * | 2018-12-21 | 2021-08-13 | R2科技公司 | 用于皮肤病学冷冻喷雾装置的自动控制和定位系统 |
CN113260460B (zh) * | 2018-12-21 | 2024-04-26 | R2科技公司 | 用于皮肤病学冷冻喷雾装置的自动控制和定位系统 |
US11974816B2 (en) | 2018-12-21 | 2024-05-07 | R2 Technologies, Inc. | Automated control and positioning systems for dermatological cryospray devices |
Also Published As
Publication number | Publication date |
---|---|
US20220233345A1 (en) | 2022-07-28 |
JP2019518541A (ja) | 2019-07-04 |
CN109310460A (zh) | 2019-02-05 |
US11266524B2 (en) | 2022-03-08 |
EP3463132A4 (en) | 2020-01-22 |
EP3463132A1 (en) | 2019-04-10 |
CN109310460B (zh) | 2022-09-27 |
KR102448859B1 (ko) | 2022-10-04 |
US20170348143A1 (en) | 2017-12-07 |
JP6975178B2 (ja) | 2021-12-01 |
KR20190015727A (ko) | 2019-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220233345A1 (en) | Medical methods and systems for skin treatment | |
US11197776B2 (en) | Method and apparatus for cryogenic treatment of skin tissue | |
EP3104796B1 (en) | Method and apparatus for affecting pigmentation of tissue | |
US20230277369A1 (en) | Method and apparatus for cryogenic treatment of skin tissue | |
KR101199185B1 (ko) | 제어식 냉각에 의한 지질 풍부 세포의 선별적인 파괴 방법 및 장치 | |
JP2019514616A (ja) | ざ瘡及び皮膚状態を処置するための皮膚凍結システム | |
JP2019505349A (ja) | 組織冷却中におけるアプリケータと皮膚との温度依存性接着 | |
US10765467B2 (en) | Medical systems, methods, and devices for hypopigmentation cooling treatments | |
AU2009200451A1 (en) | Methods and Devices for Selective Disruption of Fatty Tissue by Controlled Cooling | |
US12004797B2 (en) | Medical systems, methods, and devices for hypopigmentation cooling treatments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17807609 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2018562999 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20187037943 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2017807609 Country of ref document: EP Effective date: 20190103 |